Hematopoietic cell transplant (HCT) offers a potential medical cure for thalassemia. The procedure involves the removal of thalassemia-producing cells with healthy donor cells taken from a matching donor. The risk factors that impact the outcome of HCT include the patient’s age, the absence or presence of liver fibrosis, absence or presence of hepatomegaly.
10-15 Days
Thalassemia is described as an inherited blood disorder characterized by fewer red blood cells and lesser haemoglobin than normal. The condition causes anemia, leaving you very exhausted. Mild thalassemia may not require any treatment, but severe conditions of thalassemia may require regular blood transfusions.
Symptoms of severe thalassemia include weakness, extreme exhaustion, facial bone deformities, yellowish or pale skin, abdominal swelling, slow growth and dark urine. Other critical symptoms of severe thalassemia include:
Diagnosis of severe thalassemia is done with blood tests that reveal low count of red blood cells, smaller than normal red blood cells, pale red blood cells, lower level of haemoglobin, abnormal measure of iron count in blood, etc.
Treatment for severe thalassemia includes frequent blood transfusions and stem cell transplants. A patient requires frequent blood transfusions, possibly every week to get more iron content in blood. However, in the process, extra iron may cause damage to the organs, liver and the heart. It is necessary to take medications along with frequent blood transfusions.
Stem cells transplant (also called bone marrow transplant) is an effective treatment option for severe thalassemia. It can eliminate the need of lifelong drugs and blood transfusions to control iron overload.
Bone marrow transplant for severe thalassemia can be carried out successfully, provided there is a compatible family donor, the patient is below five years of age without a liver enlargement etc. However, older children with high ferritin levels, enlarged spleen or liver will have to undergo intensive treatment along with chelation drugs and hydroxyurea. The success rate of BMT for thalassemia is associated with 80-90% cure probability.
Before going through a stem cell transplant, these are the preparations to be taken:
Recovery of BMT thalassemia depends upon a number of factors like physical condition of the person, the severity of side effects of the transfusion, etc. Immediately after the bone marrow transplant, the patient can get back to a normal life. The stem cells infused, travel into the blood stream and it takes about a week before new blood cells start to develop. It feels normal when the new blood cells grow, but if in case of any side effects, it should be consulted with a doctor right away.